Clinical Trial Update: The Potential of Carnosine Supplementation in Optimising Cardiometabolic Health [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update exploring carnosine supplementation for improving cardiometabolic health in individuals with poor glycemic control and cardiovascu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Risk Factors
• Cognitive Function
• Poor Glycemic Control

Drugs mentioned

• Carnosine (carnosine)

Snippet

Sponsor: Monash University | Conditions: Poor Glycemic Control, Cardiovascular Risk Factors | Phase 2 | Status: UNKNOWN